
Prize4Life -- an X-PRIZE-style competition intended to stimulate innovation and produce tangible results in ALS research -- recently awarded its first prizes: Five researchers each received $15,000 to develop a biomarker for tracking the progression of ALS, a fatal disease.
If they, or anyone else, succeed in developing a verifiable biomarker by November 6, 2008, they will win $1 million. Such a biomarker would enable scientists to test for ALS before the visible onset of symptoms, similar to markers in the blood of AIDS patients. If the biomarker could be detected early enough, researchers may be able to treat patients with neuroprotective drugs to delay or prevent the disease's progression.
The founder of Prize4Life is Harvard Business School graduate Avichai Kremer, who was diagnosed with ALS in the fall of 2004. A 2006 article in the Wall Street Journal provides this portrayal of him -- which seems to fit most people his (our?) age:
An article from today's The Boston Globe offers an updated description:
Similar X-PRIZE-style competitions across multiple conditions and diseases could bring cures for many -- capitalism at its finest.
The Business of Survival [The Boston Globe]